laitimes

The first intracranial hemorrhage CT image-assisted triage software in China was approved for listing

The reporter learned from the State Drug Administration that recently, the State Food and Drug Administration approved the innovative product registration application of "intracranial hemorrhage CT image assisted triage software" after review.

According to reports, the product is composed of server side and browser side. The server side is composed of a data access and storage module, a data synchronization module, and an image processing module based on a deep learning algorithm; the browser side consists of a patient management module, a result display and editing module, and a service module. The software is delivered via FTP download.

The first intracranial hemorrhage CT image-assisted triage software in China was approved for listing

News from the website of the State Food and Drug Administration

The product is the first artificial intelligence medical software in China to realize intracranial hemorrhage triage prompts and measurement analysis based on deep learning technology, using intracranial hemorrhage detection and segmentation algorithm based on deep learning, realizing intracranial hemorrhage triage prompts and blood volume quantitative analysis functions, which can display, process, measure and analyze cranial CT scan images for triage tips for patients with ultra-acute and acute intracranial hemorrhage. Clinical use by trained physicians cannot be used alone as a basis for clinical diagnosis and treatment decisions. Products are produced by Shanghai Lianying Intelligent Medical Technology Co., Ltd.

The first intracranial hemorrhage CT image-assisted triage software in China was approved for listing

Software interface

The first intracranial hemorrhage CT image-assisted triage software in China was approved for listing

According to the State Food and Drug Administration, the product innovatively uses artificial intelligence algorithms to calculate and analyze patient images instantly, improve the speed of diagnosis, quickly screen out patients with suspected intracranial hemorrhage in the ultra-acute stage and acute stage, provide a reference for doctors to assess the degree of criticality, formulate clinical plans, and effectively help patients diagnose and treat as soon as possible. The national drug supervision and administration department will strengthen the post-market supervision of the product to protect the safety of patients' equipment.

(Guangming Daily all-media reporter Zhang Yaxiong)

Source: Guangming Daily all-media reporter Zhang Yaxiong

Editor-in-charge: Wang Zimo

Editor: Zhang Xueyu Sun Dai

Read on